New Report by BioTrends Research Group To Highlight The Launch Of ACTEMRA (tocilizumab)
Does the MS Market Need Another Interferon? Neurologists Provide Insight in the Wave One Report of LaunchTrends®: EXTAVIA
Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral Metabolism Practice Patterns Around the Globe
BioTrends Provides Insight into the Global Renal Anemia Market with the Release of Three Nephrology TreatmentTrends Publications
BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across A Variety of Physician Specialties
Page 7 of 17
